Skip to main content

Advertisement

SpringerLink
Log in

Immunohistochemical study of perforin and apoptosis stimulation fragment ligand (FasL)in active vitiligo

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Several studies demonstrated a major pathological role of melanocyte-specific cytotoxic CD8+ T cells in the pathogenesis of vitiligo. It has been suggested that apoptosis, rather than necrosis, is the mechanism of melanocyte depletion in vitiligo. The aim of this study was to evaluate the expression and distribution of perforin and apoptosis stimulation fragment ligand (FasL) in the epidermis and dermis of the perilesional and non-lesional skin of vitiligo patients in comparison to controls, to assess their possible role in mediating apoptosis in vitiligo. Twenty patients with active non-segmental vitiligo and 20 healthy controls were enrolled in the study. Skin biopsies were taken from perilesional and non-lesional skin of patients with vitiligo, as well as covered skin of controls. Immunostaining for perforin and FasL was performed and the quantitative analysis for the expression of perforin and FasL was carried out in the epidermis and dermis of biopsied specimens. Epidermal perforin, dermal perforin, epidermal FasL, dermal FasL were significantly higher in perilesional as well as non-lesional skin than controls. There was a statistically significant positive correlation between epidermal and dermal perforin in perilesional skin. There was a statistically significant positive correlation between epidermal and dermal perforin, as well as epidermal and dermal FasL in non-lesional skin. In conclusion, the significant expression of perforin and FasL in the epidermis and dermis of both perilesional and non-lesional skin of active vitiligo patients suggests the role of cytotoxic granules and apoptotic cell death pathways in the pathogenesis of active vitiligo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Benzekri L, Gauthier Y (2017) Clinical markers of vitiligo activity. J Am Acad Dermatol 76:856–862

    Article  Google Scholar 

  2. Bishnoi A, Parsad D (2018) Clinical and molecular aspects of vitiligo treatments. Int J Mol Sci 19(5):1509

    Article  Google Scholar 

  3. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang SC, Marquardt N, Gibbs A, Detlofsson E, Introini A, Forkel M, Höög C, Tjernlund A, Michaëlsson J, Folkersen L, Mjösberg J, Blomqvist L, Ehrström M, Ståhle M, Bryceson YT, Eidsmo L (2017) CD49a expression defines tissue-resident CD8+ T cells poised for cytotoxic function in human skin. Immunity 46(2):287–300

    Article  CAS  Google Scholar 

  4. Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H (2004) Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol 140(6):677–683

    Article  Google Scholar 

  5. Huang CL, Nordlund JJ, Boissy R (2002) Vitiligo: a manifestation of apoptosis? Am J Clin Dermatol 3(5):301–308

    Article  CAS  Google Scholar 

  6. Lambe T, Leung JC, Bouriez-Jones T, Silver K, Makinen K, Crockford TL, Ferry H, Forrester JV, Cornall RJ (2006) CD4 T lymphocytes-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions. J Immunol 177:3055–3062

    Article  CAS  Google Scholar 

  7. Lang KS, Caroli CC, Muhm A, Wernet D, Moris A, Schittek B, Knauss-Scherwitz E, Stevanovic S, Rammensee HG, Garbe C (2001) HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. J Invest Dermatol 116:891–897

    Article  CAS  Google Scholar 

  8. Le Gal FA, Avril MF, Bosq J, Lefebvre P, Deschemin JC, Andrieu M, Knauss-Scherwitz E, Stevanovic S, Rammensee HG, Garbe C (2001) Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo. J Invest Dermatol 117:1464–1470

    Article  Google Scholar 

  9. Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK (1996) Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 148(4):1219–1228

    PubMed  PubMed Central  Google Scholar 

  10. Li M, Sun D, Li C, Zhang Z, Gao L, Li K, Li H, Gao T (2008) Functional polymorphisms of the FAS gene associated with risk of vitiligo in Chinese populations: a case-control analysis. J Invest Dermatol 128:2820–2824

    Article  CAS  Google Scholar 

  11. Lopez JA, Susanto O, Jenkins MR, Lukoyanova N, Sutton VR, Law RH, Johnston A, Bird CH, Bird PI, Whisstock JC, Trapani JA, Saibil HR, Voskoboinik I (2013) Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. Blood 121:2659–2668

    Article  CAS  Google Scholar 

  12. Nabhani S, Ginzel S, Miskin H, Revel-Vilk S, Harlev D, Fleckenstein B, Hönscheid A, Oommen PT, Kuhlen M, Thiele R, Laws HJ, Borkhardt A, Stepensky P, Fischer U (2015) Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease. Haematologica 100(9):1189–1198

    Article  CAS  Google Scholar 

  13. Njoo MD, Das PK, Bos JD, Westerhof W (1999) Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol 135(4):407–413

    Article  CAS  Google Scholar 

  14. Ongenae K, Van Geel N, Naeyaert JM (2003) Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 16:90–100

    Article  Google Scholar 

  15. Pretti Aslanian FM, Noé RA, Antelo DP, Farias RE, Das PK, Galadari I, Cuzzi T, Filgueira AL (2008) Immunohistochemical findings in active vitiligo including depigmenting lesions and non-lesional skin. Open Dermatol J 2:105–110

    Article  Google Scholar 

  16. Pretti Aslanian FM, Noe RA, Cuzzi T, Filgueira AL (2007) Abnormal histological findings in active vitiligo include the normal-appearing skin. Pigment Cell Res 20(2):144–145

    Article  Google Scholar 

  17. Saleh FY, Awad SS, Sadek IM (2013) Lymphocytic expression of Fas and FasL apoptotic markers in vitiligo. Clin Med Res 2:105–109

    Article  Google Scholar 

  18. Su SC, Chung WH (2014) Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions. Toxins (Basel) 6(1):194–210

    Article  Google Scholar 

  19. Sweet RD (1978) Vitiligo as a Koebner phenomenon. Br J Dermatol 99:223–224

    Article  CAS  Google Scholar 

  20. van den Boorn JG, Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, Melief CJ, Vyth-Dreese FA, Luiten RM (2009) Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 129:2220–2232

    Article  Google Scholar 

  21. van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P (2000) Local immune response in skin of generalized vitiligo patients Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 80(8):1299–1309

    Article  CAS  Google Scholar 

  22. Wehrli P, Viard I, Bullani R, Tschopp J, French LE (2000) Death receptors in cutaneous biology and disease. J Invest Dermatol 115(2):141–148

    Article  CAS  Google Scholar 

  23. Wu J, Zhou M, Wan Y, Xu A (2013) CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis. Mol Med Rep 7(1):237–241

    Article  CAS  Google Scholar 

  24. Yang Y, Li S, Zhu G, Zhang Q, Wang G, Gao T, Li C, Wang L, Jian Z (2017) A similar local immune and oxidative stress phenotype in vitiligo and halo nevus. J Dermatol Sci 87(1):50–59

    Article  CAS  Google Scholar 

  25. You S, Cho Y, Byun JS, Shin EC (2013) Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo. Clin Exp Immunol 174(1):38–44

    Article  CAS  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Department of Dermatology, Faculty of Medicine, Cairo University, Post office box 109, El-Malek El-Saleh, Cairo, Egypt

    Akmal Saad Hassan & Sara Bahaa Mahmoud

  2. Department of Histology, Faculty of Medicine, Cairo University, Post office box 109, El-Malek El-Saleh, Cairo, Egypt

    Safinaz Salah Eldin Sayed

  3. Cairo, Egypt

    May Malek Kohil

Authors
  1. Akmal Saad Hassan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. May Malek Kohil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Safinaz Salah Eldin Sayed
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sara Bahaa Mahmoud
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sara Bahaa Mahmoud.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hassan, A.S., Kohil, M.M., Sayed, S.S.E. et al. Immunohistochemical study of perforin and apoptosis stimulation fragment ligand (FasL)in active vitiligo. Arch Dermatol Res 313, 453–460 (2021). https://doi.org/10.1007/s00403-020-02117-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-020-02117-7

Keywords

Search

Navigation